Global Viral Molecular Diagnostics Market by Product & Data Validation, Analysis and Forecast 2022
ReportsWeb.com published “Viral Molecular Diagnostics Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
(EMAILWIRE.COM, January 05, 2017 ) According to Publisher, the Global Viral Molecular Diagnostics Market accounted for $XX million in 2015 and is expected to grow at a CAGR of XX% to reach $XX million by 2022. Growing incidence of viral diseases, rising aged population, technological advances in molecular diagnostics, increasing awareness about viral diseases and rising government initiatives in several regions are the key factors fueling the market growth. On the other hand, absence of skilled professionals and huge cost of molecular diagnostics are some of the key factors limiting the viral molecular diagnostics market growth.
North America is the major market for the viral molecular diagnostics followed by the Western Europe owing to growing number of key players within this market. Superior infrastructure and top awareness levels about various viral diseases among the people in these regions are the key factors attributed for their highest share. Asia-Pacific is the fastest growing market for various viral molecular diagnostic tests, owing to growing incidence of viral infections in this market.
For more information http://www.reportsweb.com/viral-molecular-diagnostics-global-market-outlook-2015-2022
Some of the key players in the global viral molecular diagnostics market include Meridian Bioscience Inc., Becton Dickinson and Company, F. Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Thermo Fisher Scientific Corporation, BioMerieux SA, Auto Genomics Inc., Qiagen NV, Affymetrix Inc., Illumina Inc., Gen-Probe Inc., Roche Molecular Diagnostics, Siemens, Cepheid and Beckman Coulter.
Applications Covered:
- Respiratory Syncytial Virus
- Hepatitis
- AIDS
- Influenza
- Others
Technologies Covered:
- Real time PCR (RT-PCR)
- Polymerase chain reaction (PCR)
- Nucleic Acid Sequence Based Amplification
- Other Molecular Diagnostic methods
- Isothermal nucleic acid amplification technology (INAAT)
- Microarrays
- In situ hybridization
End User's Covered:
- Academic Institutions
- Hospitals
- Ambulatory clinics
- Diagnostic Laboratories
Products Covered:
- Reagents
- Instrument
- Others
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- Rest of Asia Pacific
- Rest of the World
- Middle East
- Brazil
- Argentina
- South Africa
- Egypt
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001216337/sample
11 Company Profiling
11.1 Meridian Bioscience Inc.
11.2 Becton Dickinson and Company
11.3 F. Hoffmann-La Roche Ltd.
11.4 Abbott Laboratories Inc.
11.5 Thermo Fisher Scientific Corporation
11.6 BioMerieux SA
11.7 Auto Genomics Inc.
11.8 Qiagen NV
11.9 Affymetrix Inc.
11.10 Illumina Inc.
11.11 Gen-Probe Inc.
11.12 Roche Molecular Diagnostics
11.13 Siemens
11.14 Cepheid
11.15 Beckman Coulter
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001216337/buying
North America is the major market for the viral molecular diagnostics followed by the Western Europe owing to growing number of key players within this market. Superior infrastructure and top awareness levels about various viral diseases among the people in these regions are the key factors attributed for their highest share. Asia-Pacific is the fastest growing market for various viral molecular diagnostic tests, owing to growing incidence of viral infections in this market.
For more information http://www.reportsweb.com/viral-molecular-diagnostics-global-market-outlook-2015-2022
Some of the key players in the global viral molecular diagnostics market include Meridian Bioscience Inc., Becton Dickinson and Company, F. Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Thermo Fisher Scientific Corporation, BioMerieux SA, Auto Genomics Inc., Qiagen NV, Affymetrix Inc., Illumina Inc., Gen-Probe Inc., Roche Molecular Diagnostics, Siemens, Cepheid and Beckman Coulter.
Applications Covered:
- Respiratory Syncytial Virus
- Hepatitis
- AIDS
- Influenza
- Others
Technologies Covered:
- Real time PCR (RT-PCR)
- Polymerase chain reaction (PCR)
- Nucleic Acid Sequence Based Amplification
- Other Molecular Diagnostic methods
- Isothermal nucleic acid amplification technology (INAAT)
- Microarrays
- In situ hybridization
End User's Covered:
- Academic Institutions
- Hospitals
- Ambulatory clinics
- Diagnostic Laboratories
Products Covered:
- Reagents
- Instrument
- Others
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- Rest of Asia Pacific
- Rest of the World
- Middle East
- Brazil
- Argentina
- South Africa
- Egypt
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001216337/sample
11 Company Profiling
11.1 Meridian Bioscience Inc.
11.2 Becton Dickinson and Company
11.3 F. Hoffmann-La Roche Ltd.
11.4 Abbott Laboratories Inc.
11.5 Thermo Fisher Scientific Corporation
11.6 BioMerieux SA
11.7 Auto Genomics Inc.
11.8 Qiagen NV
11.9 Affymetrix Inc.
11.10 Illumina Inc.
11.11 Gen-Probe Inc.
11.12 Roche Molecular Diagnostics
11.13 Siemens
11.14 Cepheid
11.15 Beckman Coulter
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001216337/buying
Contact Information:
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results